Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Current Computer-Aided Drug Design|January 19, 2016
Artificial Neural Network Analysis of Pharmacokinetic and Toxicity Properties of Lead Molecules for Dengue Fever, Tuberculosis and MalariaShahul H Nilar, Suresh B Lakshminarayana, Ngai Ling Ma, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|July 17, 2003
Absolute potassium cation affinities (PCAs) in the gas phaseJustin Kai-Chi Lau, Carrie Hoi Shan Wong, Po Shan Ng, et al.Antiviral Research|October 6, 2009
A small molecule fusion inhibitor of dengue virusMee Kian Poh, Andy Yip, Summer Zhang, et al.Novartis Foundation Symposium|February 27, 2007
Finding new medicines for flaviviral targetsThomas H Keller, Yen Liang Chen, John E Knox, et al.European Journal of Medicinal Chemistry|November 7, 2015
Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agentsPearly Shuyi Ng, Ujjini H Manjunatha, Srinivasa P S Rao, et al.Antimicrobial Agents and Chemotherapy|February 19, 2009
A small-molecule dengue virus entry inhibitorQing-Yin Wang, Sejal J Patel, Eric Vangrevelinghe, et al.Journal of Medicinal Chemistry|October 27, 2006
Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitorsJohn E Knox, Ngai Ling Ma, Zheng Yin, et al.The Journal of Antimicrobial Chemotherapy|July 1, 2008
Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosisMekonnen Kurabachew, Stephen H J Lu, Philipp Krastel, et al.The Journal of General Virology|July 12, 2007
Yellow fever virus NS3 protease: peptide-inhibition studiesKristina Löhr, John E Knox, Wai Yee Phong, et al.Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitorsZheng Yin, Sejal J Patel, Wei-Ling Wang, et al.Pageof 3